These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35547222)

  • 1. DyeVert Contrast Reduction System Use in Patients Undergoing Coronary and/or Peripheral Angiography: A Systematic Literature Review and Meta-Analysis.
    Tarantini G; Prasad A; Rathore S; Bansal S; Gottfried R; Rosenkranz AR; Briguori C; Yaghoubi M; Mashayekhi A; Javanbakht M; Moloney E
    Front Med (Lausanne); 2022; 9():841876. PubMed ID: 35547222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimizing radiographic contrast administration during coronary angiography using a novel contrast reduction system: A multicenter observational study of the DyeVert™ plus contrast reduction system.
    Gurm HS; Mavromatis K; Bertolet B; Kereiakes DJ; Amin AP; Shah AP; Hanzel GS; Rao S; Thomas JL; Kumar G
    Catheter Cardiovasc Interv; 2019 Jun; 93(7):1228-1235. PubMed ID: 30393942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast media volume reduction with the DyeVert
    Paolucci L; De Micco F; Bezzeccheri A; Scarpelli M; Esposito G; Airoldi F; Focaccio A; Briguori C
    Catheter Cardiovasc Interv; 2023 Oct; 102(4):655-662. PubMed ID: 37668067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Feasibility Study of the DyeVert™ Plus Contrast Reduction System to Reduce Contrast Media Volumes in Percutaneous Coronary Procedures Using Optical Coherence Tomography.
    Zimin VN; Jones MR; Richmond Iv T; Durieux JC; Alaiti AM; Pereira GTR; Vergara-Martel A; Pizzato PE; Zago EI; Dallan LA; Bezerra HG
    Cardiovasc Revasc Med; 2021 Sep; 30():40-46. PubMed ID: 33046416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a contrast media volume control device on acute kidney injury rate in patients with acute coronary syndrome.
    Briguori C; Golino M; Porchetta N; Scarpelli M; De Micco F; Rubino C; Focaccio A; Signoriello G
    Catheter Cardiovasc Interv; 2021 Jul; 98(1):76-84. PubMed ID: 32682348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a Contrast Modulation System on Contrast Media Use and the Rate of Acute Kidney Injury After Coronary Angiography.
    Mehran R; Faggioni M; Chandrasekhar J; Angiolillo DJ; Bertolet B; Jobe RL; Al-Joundi B; Brar S; Dangas G; Batchelor W; Prasad A; Gurm HS; Tumlin J; Stone GW
    JACC Cardiovasc Interv; 2018 Aug; 11(16):1601-1610. PubMed ID: 30139467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast Media Volume Control and Acute Kidney Injury in Acute Coronary Syndrome: Rationale and Design of the REMEDIAL IV Trial.
    Briguori C; Mariano E; D'Agostino A; Scarpelli M; Focaccio A; Evola S; Esposito G; Sangiorgi GM
    J Soc Cardiovasc Angiogr Interv; 2023; 2(4):100980. PubMed ID: 39131657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DyeVert™ PLUS EZ System for Preventing Contrast-Induced Acute Kidney Injury in Patients Undergoing Diagnostic Coronary Angiography and/or Percutaneous Coronary Intervention: A UK-Based Cost-Utility Analysis.
    Javanbakht M; Hemami MR; Mashayekhi A; Branagan-Harris M; Zaman A; Al-Najjar Y; O'Donoghue D; Fath-Ordoubadi F; Wheatcroft S
    Pharmacoecon Open; 2020 Sep; 4(3):459-472. PubMed ID: 31989464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast Minimization With the New-Generation DyeVert Plus System for Contrast Reduction and Real-Time Monitoring During Coronary and Peripheral Procedures: First Experience.
    Corcione N; Biondi-Zoccai G; Ferraro P; Messina S; Maresca G; Avellino R; Napolitano G; Cavarretta E; Giordano A
    J Invasive Cardiol; 2017 Aug; 29(8):259-262. PubMed ID: 28756419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of a novel contrast reduction system on contrast savings in coronary angiography - The DyeVert randomised controlled trial.
    Desch S; Fuernau G; Pöss J; Meyer-Saraei R; Saad M; Eitel I; Thiele H; de Waha S
    Int J Cardiol; 2018 Apr; 257():50-53. PubMed ID: 29373136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A first in human evaluation of a novel contrast media saving device.
    Sapontis J; Barron G; Seneviratne S; Fuernau G; Eitel I; Ledwoch J; Thiele H; Saad M; de Waha S; Poess J; Desch S
    Catheter Cardiovasc Interv; 2017 Nov; 90(6):928-934. PubMed ID: 28471046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the DyeVert System in Chronic Total Occlusion Percutaneous Coronary Intervention.
    Tajti P; Xenogiannis I; Hall A; Burke MN; Chavez I; Garcia S; Gössl M; Mooney M; Poulose A; Sorajja P; Wang Y; Vemmou E; Nikolakopoulos I; Morley P; Rangan BV; Ungi I; Brilakis ES
    J Invasive Cardiol; 2019 Sep; 31(9):253-259. PubMed ID: 31478890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The global incidence and mortality of contrast-associated acute kidney injury following coronary angiography: a meta-analysis of 1.2 million patients.
    Lun Z; Liu L; Chen G; Ying M; Liu J; Wang B; Liang J; Yang Y; Chen S; He Y; Chung EYM; Chen J; Ye J; Liu Y
    J Nephrol; 2021 Oct; 34(5):1479-1489. PubMed ID: 34076881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remote Ischemic Conditioning for Preventing Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions/Coronary Angiography: A Meta-Analysis of Randomized Controlled Trials.
    Bei WJ; Duan CY; Chen JY; Wang K; Liu YH; Liu Y; Tan N
    J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):53-63. PubMed ID: 26112028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radial vs femoral access for the prevention of acute kidney injury (AKI) after coronary angiography or intervention: A systematic review and meta-analysis.
    Andò G; Gragnano F; Calabrò P; Valgimigli M
    Catheter Cardiovasc Interv; 2018 Dec; 92(7):E518-E526. PubMed ID: 30244540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Contrast-Associated Acute Kidney Injury in Patients Undergoing Peripheral Angiography with Carbon Dioxide Compared to Iodine-Containing Contrast Agents: A Systematic Review and Meta-Analysis.
    Wagner G; Glechner A; Persad E; Klerings I; Gartlehner G; Moertl D; Steiner S
    J Clin Med; 2022 Dec; 11(23):. PubMed ID: 36498777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of renin-angiotensin system blockers on contrast-induced acute kidney injury in patients with normal or mild-to-moderate reduced kidney function undergoing coronary angiography: A systematic review and meta-analysis.
    Yamada T; Fujisaki T; Chopra N; Yamaji T; Azushima K; Kobayashi R; Kinguchi S; Urate S; Suzuki T; Abe E; Wakui H; Tamura K; Steinberg D
    Clin Nephrol; 2020 Nov; 94(5):227-236. PubMed ID: 32870151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of N-acetylcysteine on prevention of contrast-associated acute kidney injury in patients with STEMI undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomised controlled trials.
    Guo Z; Liu J; Lei L; Xue Y; Liu L; Huang H; Chen S; Liu Y; Lin Y; Tao J; Xu Q; Wu K; Zhang L; Chen JY
    BMJ Open; 2020 Oct; 10(10):e039009. PubMed ID: 33067289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing contrast-induced acute kidney injury with probucol and hydration in patients with coronary heart disease: A systematic review and meta-analysis of randomized controlled trials.
    Cui X; Xie B; Wang H; Liu F; Mei L; Qin F; Zhang J; Yi X
    Medicine (Baltimore); 2023 Mar; 102(11):e33273. PubMed ID: 36930109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.